Luigi De Petris - Concepedia

Author

Luigi De Petris

Also Known As

De Petris, Luigi, L De Petris, L. De Petris, L. Petris, L. de Petris, L.D. Petris, Luigi De Petris, Luigi De Petris, Luigi de Petris, Stitt, Larry

149

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet KTH Royal Institute of Technology Roche (Switzerland)Uppsala University

About

Luigi De Petris is an author at Karolinska University Hospital specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	24	698
2	Health Sciences	4	4	141
3	Public Health	2	2	49
4	Education	1	1	12
5	Biology	1	1	30

Luigi De Petris

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study Sai‐Hong Ignatius Ou, Jin Seok Ahn, Luigi De Petris, Journal of Clinical Oncology	2015	578
Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With <i>ALK</i> -Positive Non–Small-Cell Lung Cancer Shirish M. Gadgeel, Alice T. Shaw, Ramaswamy Govindan, Journal of Clinical Oncology	2016	195
The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, Nature Cancer	2022	120
Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors Marcus Skribek, Konstantinos Rounis, Soren Afshar, European Journal of Cancer	2021	98
Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK -positive Non-Small Cell Lung Cancer James Chih‐Hsin Yang, Sai‐Hong Ignatius Ou, Luigi De Petris, Journal of Thoracic Oncology	2017	82
Second-Line Treatment of Advanced Non-small Cell Lung Cancer Cesare Gridelli, Andrea Ardizzoni, Fortunato Ciardiello, Journal of Thoracic Oncology Second-line TreatmentMedicineBronchial NeoplasmCombined Modality TreatmentCancer Treatment	2008	67
Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression Per Hydbring, Luigi De Petris, Yanming Zhang, Lung Cancer MedicineExosomal Rna-profilingPathologyCancer GenomicsExtracellular Microvesicles	2018	65
Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer Luigi De Petris, Lukas M. Orre, Lena Kanter, Lung Cancer Tumor BiologyS100a6 CorrelatesOncologyMedicineImmunology	2008	63
Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion Maria Pernemalm, Luigi De Petris, Hanna Eriksson, PROTEOMICS	2009	54
Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib Peter N. Morcos, Yumi Cleary, Elena Guerini, Clinical Pharmacology in Drug Development ImmunologyPharmacotherapyAlk+ NsclcPharmacodynamic ModelingDrug Resistance	2016	46

Page 1